Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (6500)	12/15/1998 8:17:00 PM
From: BigKNY3	Read Replies (1) \| Respond to of 9523

Rite Aid posts higher profits, exceeding forecasts By Gilles Castonguay NEW YORK, Dec 14 (Reuters) - Rite Aid Corp. <RAD.N>, a leading U.S. drug-store chain, rang up strong growth in sales and profits in its fiscal third quarter, beating market earnings expectations by a penny a share. Rite Aid, based in Camp Hill, Pa., said on Monday that earnings rose to $86.9 million for the quarter ended Nov. 29, up 27.9 percent from $67.9 million for the same period a year ago. Diluted earnings per share rose to 33 cents against 26 cents a year earlier, it said. Analysts estimated earnings at an average 32 cents a share, according to First Call Corp., which tracks market forecasts. Rite Aid, which operates more than 3,800 stores in 32 states, said sales for the quarter rose 8.2 percent to $3.1 billion from $2.9 billion a year ago. Sales at stores open at least a year rose 8.3 percent, it added. "All in all, it was a very good quarter," said Joseph Ronning, an analyst at Brown Brothers Harriman. "There were good, strong sales on the East Coast, led by strong pharmaceutical sales." Despite the strong performance, Rite Aid shares ended $1.94 lower at $41.19 on the New York Stock Exchange, bedeviling some analysts. "I can't explain it," said Philip Muldoon at McDonald & Co. Investments. "They met my forecast." Rite Aid spokeswoman Sarah Datz told Reuters the chain attributed the rise in sales and profits to greater drug use by the country's aging population, as well as the introduction of new drugs such as Pfizer Inc.'s <PFE.N> Viagra potency pill. Rite Aid said prescription drug sales accounted for 56.3 percent of total sales in the third quarter. A year ago, the figure was 51.4 percent. Datz said food, health and beauty aids comprised the remainder of sales. On Nov. 17, Rite Aid announced its $1.5 billion acquisition of PCS Health Systems from Eli Lilly and Co. <LLY.N>, placing it among the country's largest providers of prescription drug benefits to employers and other plan sponsors. Frank Bergonzi, the chain's chief financial officer, told analysts in a conference call that he expected PCS to raise earnings by 1 cent a share to 3 cents in the next fiscal year.